Miura Mauricio Schreiner, Saleh Catia, de Andrade Marina, Assmann Melina, Ayres Marcio, Lubianca Neto José Faibes
Department of Medical Surgery of Universidade Federal de Ciências da Saúde de Porto Alegre and Division of Pediatric Otorhinolaryngology at Hospital da Criança Santo Antênio, Programa de Pós-Graduação em Ciências Médicas-Faculdade de Medicina da Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Otolaryngol Head Neck Surg. 2009 Sep;141(3):322-8. doi: 10.1016/j.otohns.2009.05.032.
Tonsillectomy, with or without adenoidectomy, is one of the most common surgical procedures in pediatric otolaryngology. Despite its relative simplicity, pain is the main cause of morbidity in the postoperative period. We determined the effect of topical sucralfate on reduction of oropharyngeal pain in children submitted to adenotonsillectomy. Secondary outcomes were otalgia, analgesic use, type of diet, secondary bleeding, vomiting, fever, and weight loss.
Double-blind, randomized clinical trial.
Tertiary hospital.
Eighty-two children of both sexes between four and 12 years old submitted to adenotonsillectomy were evaluated. They were allocated to receive topical sucralfate or placebo in intraoperative and postoperative periods four times a day for five days. Pain was measured through faces pain scale.
Reduction in oropharyngeal pain was significant with use of sucralfate during five days of evaluation (mean, 95% confidence interval, and P value); day 1: 2.05, 1.53-2.58, P = 0.000; day 2: 2.1, 1.51-2.70, P = 0.001; day 3: 1.44, 0.88-1.99, P = 0.003; day 4: 1.13, 0.58-1.55, P = 0.027; day 5: 0.67, 0.26-1.04, P = 0.021). There was no difference in secondary outcomes.
We found beneficial effect of use of sucralfate in reduction of oropharyngeal pain in the postoperative period of adenotonsillectomy. However, topical sucralfate does not have a potent effect to the point of being utilized as a single analgesic treatment. Because it is simple, safe, tolerated, and low-cost, it is an important tool as adjuvant treatment of post-tonsillectomy pain.
扁桃体切除术,无论是否同时行腺样体切除术,都是小儿耳鼻喉科最常见的外科手术之一。尽管该手术相对简单,但疼痛是术后发病的主要原因。我们确定了局部应用硫糖铝对接受腺样体扁桃体切除术儿童口咽疼痛减轻的影响。次要结果包括耳痛、镇痛药物使用、饮食类型、继发性出血、呕吐、发热和体重减轻。
双盲随机临床试验。
三级医院。
对82例年龄在4至12岁之间接受腺样体扁桃体切除术的儿童进行评估。他们被分配在术中和术后每天4次接受局部硫糖铝或安慰剂治疗,持续5天。通过面部疼痛量表测量疼痛。
在评估的5天中,使用硫糖铝后口咽疼痛明显减轻(平均值、95%置信区间和P值);第1天:2.05,1.53 - 2.58,P = 0.000;第2天:2.1,1.51 - 2.70,P = 0.001;第3天:1.44,0.88 - 1.99,P = 0.003;第4天:1.13,0.58 - 1.55,P = 0.027;第5天:0.67,0.26 - 1.04,P = 0.021)。次要结果无差异。
我们发现硫糖铝在腺样体扁桃体切除术后减轻口咽疼痛方面有有益作用。然而,局部应用硫糖铝的效果不足以作为单一的镇痛治疗方法。由于其简单、安全、耐受性好且成本低,它是扁桃体切除术后疼痛辅助治疗的重要工具。